BioScrip (BIOS) Tops Q3 EPS Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections, more earnings
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts BIOS Hot Sheet
Join SI Premium – FREE
BioScrip (NASDAQ: BIOS) reported Q3 EPS of $0.42, $0.40 better than the analyst estimate of $0.02. Revenue for the quarter came in at $244 million versus the consensus estimate of $240.08 million.
For earnings history and earnings-related data on BioScrip (BIOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley bearish on Coinbase, slashes target on weaker recovery
- US Lime and Minerals (USLM) PT Lowered to $131 at Freedom Broker
- Papa John's (PZZA) PT Lowered to $21 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
